Spero Therapeutics, Inc. SPRO Q3 2025 earnings

FAQ

When did Spero Therapeutics, Inc. report Q3 2025 earnings?

Spero Therapeutics, Inc. (SPRO) reported Q3 2025 earnings on November 13, 2025 after market close.

What were Spero Therapeutics, Inc.'s Q3 2025 revenue and EPS?

Spero Therapeutics, Inc. reported revenue of $3.0M and eps of $-0.13 for Q3 2025.

Did Spero Therapeutics, Inc. beat estimates in Q3 2025?

Revenue missed the consensus estimate of $12.0M by $9.0M. EPS beat the consensus estimate of $-0.25 by $0.12.

How did Spero Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 77.4% from $13.5M a year earlier and eps grew 59.4% from $-0.32.

Where can I find Spero Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001193125-25-280518) and the 10-Q periodic report (0001193125-25-280174) directly on SEC EDGAR. The filing index links above go to sec.gov.